调节蛋白质酶子单元选择性的syringolins的调节
Kengo Tatsumi1, Shun Kitahata1, Yuya Komatani1
1Faculty of Pharmaceutical Science, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.
Bioorganic & medicinal chemistry
|May 5, 2024
概括
研究人员使用syringolin B开发了新的蛋白质酶子单元抑制剂.结构-活性关系研究表明,特定的替代剂可以为β5和β2蛋白质酶子单元赋予选择性.
科学领域:
- 药用化学 医学化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 蛋白酶体是一个关键的蛋白质复合体,参与细胞调节.
- 开发选择性蛋白酶体抑制剂是针对性治疗的关键.
- 赛林戈林B作为一个有前途的脚手架,用于新的抑制剂设计.
研究的目的:
- 开发基于西林戈林B基架的选择性或双蛋白酶子单元抑制剂.
- 为了研究林B类型的结构-活性关系,以研究子单元选择性.
- 为了确定赋予特定蛋白质组子单元的选择性替代剂.
主要方法:
- 用各种替代剂在麦克罗拉克坦部分的3位处合成西灵林B类似物.
- 结构-活性关系 (SAR) 研究,以评估抑制剂的有效性和选择性.
- 在S1亚站点设计针对特定氨基酸残留物 (Met45,Glu53,Arg45) 的类型.
主要成果:
- 系统的SAR研究提供了关于子单元选择性抑制活性起源的见解.
- 特定的替代物被确定为β5和β2蛋白酶子单元赋予选择性.
- 修改3位置换剂的策略足以实现子单元选择性.
结论:
- 修改syringolin B支架可以产生具有定义子单元选择性的蛋白酶体抑制剂.
- 这种方法为开发向蛋白酶基治疗方法提供了一个可行的策略.
- 这些选择性抑制剂的进一步开发为各种治疗应用提供了潜力.
相关概念视频
The Proteasome
830
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
830
The Proteasome Structure
748
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
748
Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K


